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The development of novel antimicrobial materials for biomedical application in indwelling devices such as catheters is very
important as the resistance of the pathogens responsible for nosocomial infections towards recent systems has been emerging
with an increasing rate. The work presented here is focused on the preparation and characterization of an antimicrobial
polymeric system composed of poly(vinyl chloride) in combination with crystal violet as a model compound of organic ionic
active species. The antimicrobial activity of the system against gram-negative bacteria Escherichia coli, gram-positive bacteria
Staphylococcus aureus and yeasts Candida albicans as the representative microorganisms were evaluated with a disk-diffusion
test. The release profile of the active substance was observed with UV-VIS spectrometry. The mechanical properties of the
prepared material were tested to verify that they were not altered with respect to the original medical-grade polymer matrix.
Keywords: poly(vinyl chloride), crystal violet, antibacterial, antimicrobial, release
Pomemben je razvoj novega protimikrobnega materiala za biomedicinsko uporabo notranjih pripomo~kov, kot so katetri, ker se
vedno pogosteje pojavlja odpornost patogenov, odgovornih za bolni{ni~ne oku`be. Predstavljeno delo je osredinjeno na pripravo
in karakterizacijo protimikrobnega polimernega sistema, ki ga sestavlja polivinilklorid v kombinaciji s kristal violetom kot
model za spojine organskih ionskih aktivnih vrst. S plo{~inskim difuzijskim preizkusom je bila ocenjena protimikrobna dejav-
nost sistema proti predstavnikom mikroorganizmov: gramnegativni bakteriji Escherichia coli, grampozitivni bakteriji
Staphylococcus aureus in kvasovkam Candida albicans. Profil sprostitve aktivnih snovi je bil opazovan z UV-VIS-spektro-
metrijo. Mehanske lastnosti pripravljenega materiala so bile preizku{ene, da bi potrdili, da niso druga~ne od navadnega
medicinskega polimera.
Klju~ne besede: poli(vinil) klorid, kristal violet, protibakterijski, protimikrobni, spro{~anje
1 INTRODUCTION
Polymers are known for their high versatility and
excellent physical-chemical properties and, in some
cases, they are suitable as biomaterials for the medical
sector and packaging industry. As a candidate for these
applications, the third most common polymer, poly(vinyl
chloride) (PVC), can be considered due to its high
mechanical and chemical resistance, inertness against
biological fluids and a wide range of processing
possibilities.1–3Among many products, urinal catheters,
blood bags and cardiovascular implants are typical items
used in the medical sector; nevertheless, they exhibit a
vulnerability towards surface bacterial colonization.2,4
Therefore, it is important to enhance their antimicrobial
properties by modifying the surfaces of such materials
with a plasma treatment, corona discharge and chemical
grafting.5,6 Another promising strategy of modifying
PVC is to incorporate an antimicrobial substance within
the polymer matrix.4,7,8 Such modifications have long-
term effects and are relatively easy to perform, showing
high rates of success. The solvent-cast technique allow-
ing a preparation of the films with extremely high quality
requirements and great uniformity of the thickness is
often employed due to its advantage of easy blending of
the films with the active molecular compounds soluble in
the used solvent system.9,10 The effectiveness of the anti-
microbial properties of such films is strongly dependent
on the release profile of the antimicrobial substance from
the polymer matrix.11
Organic substances migrate, over time, out of the
polymer matrix and onto the polymer surface and are
then released into the surrounding liquids. Migration
occurs as the organic molecules follow down a concen-
tration gradient and exit the plastic. The migration is
driven by the inherent compatibility differences between
the organic antimicrobials and the polymer substrates in
which they are dispersed. The losses of the organic mole-
cules into the environment are replenished by the
additives within the substrate volume. The benefit of this
mode of action is that it can have a very high activity
rate, and the migratory molecules can very quickly inte-
ract with large numbers of microbes. This does, however,
affect the lifespan of the activity, as the additives leach
out over time, emptying the polymer’s reservoir. The
concentration and choice of the respective organic
additive depend on the level of efficacy required and the
duration of the action needed.12
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An antimicrobial agent release that is too fast can be
harmful under certain conditions and perceived as
undesirable. Besides inorganic fillers, ionic organic com-
pounds can provide a real option in the material design
having long-lasting mild effects due to their relatively
slow migration rates. An organic salt structure comprised
of a large bulky organic cation and a small inorganic
anion can be considered to have the migration rates in a
polyolefinic matrix slow enough in comparison with the
molecular organic antimicrobial additives. As a well-
known model representative for this class of compounds
crystal violet (CV) can be chosen. It is a triarylmethane
dye formerly used in medicine due to its antibacterial,
antifungal, anthelmintic and antiseptic properties.13–15
CV was generally considered to be safe for a long time
in the history of medicine; however, many studies have
reported that CV has potentially mutagenic and carcino-
genic effects on humans and animals.16–19 In spite of this,
CV is an excellent model compound for the release-pro-
file studies. This dye can be easily mixed with polymers;
it has a very good and broad antimicrobial activity,
giving deep violet colour to its solutions; hence, its
concentration can be easily monitored with an UV-VIS
absorption spectrometer.
This study focuses on the modification of a medical-
grade PVC with a crystal-violet (CV) addition, using the
solvent-casting technique resulting in a model organic
antimicrobial polymer system. Its composition, morpho-
logy, mechanical properties, antimicrobial tests and the
kinetics of the CV release from a polymeric matrix in
water and physiological solution used as model liquids,
were investigated in the presented work.
2 EXPERIMENTAL WORK
2.1 Materials
Medical-grade thermoplastic plasticized poly(vinyl
chloride) (PVC) compound RB3 was purchased from
Modenplast Medical (Italy). This material is in compli-
ance with the European Pharmacopeia and biocompa-
tible according to ISO 10993, USP, Class VI. Crystal
violet C25N3H30Cl (CV) and cyklohexanone C6H10O
(CYH) were purchased from PENTA (Czech Republic).
All the chemicals were of the analytical grade and used
as received without further purification. Demineralized
water was used for all of these experiments.
2.2 Sample preparation
PVC/CYH/CV films were prepared with the solvent-
casting technique. In the first step a solution of CV in
CYH was prepared: 0.2522 g of CV was added to 250
mL CYH to get a concentration of 1 g/L. 20.005 raw
PVC in the form of granules was dissolved in 300 mL of
CYH during a period 16 h at the room temperature under
continuous stirring. The amount of 250 mL of the CV
solution was added and this blend was left to mix for
another 8 h. Finally, the mixing was finished with a
sonication of the solution for 15 min in an ultrasonic
bath. The solution was then poured into glass dishes and
the solvent was allowed to evaporate at the laboratory
temperature for 10 d. The PVC/CYH control sample was
prepared with the same procedure, but without
incorporating the CV. The conditions for the film
preparation were chosen on the basis of practical
laboratory experience, with the aim to achieve the
smoothest fine films of comparable quality. The
thickness of the resultant films was about 500 μm.
2.3 Characterization
2.3.1 Infrared absorption spectroscopy
A FTIR analysis was used to compare the PVC
pellets, PVC/CYH and PVC/CYH/CV films. All the
measurements were performed with a Nicolet 6700
spectrophotometer (Nicolet, Czech Republic) with the
ATR accessory and the Ge crystal for the attenuated-
total-reflection method.
2.3.2 SEM analysis
The micrographs of the prepared materials were
taken with a Vega II LMU scanning electron microscope
(Tescan, Czech Republic). The freeze fracture surfaces
were obtained with liquid nitrogen and observed after the
coating with a thin layer of gold/palladium by an SC
7640 sputter coater (Quorum Technologies Ltd, UK).
2.3.3 Tensile tests
The effects of the CV added to the PVC matrix on the
mechanical properties were studied using a tensile test.
The specimens for the test were cut from the prepared
film samples as rectangular stripes with the width of 5
mm and the length of 36 mm. The specimens were tested
on a tensile testing machine Testometric M350-5CP
(LABOR machine, Ltd.) at 25 °C according to standard
ISO 37:2005. The speed of the moving clamp was 500
mm/min. The Young´s modulus, the stress at break and
the strain at break were determined. All the samples
were measured in 5 replicates and standard deviations
were estimated.
2.3.4 Antimicrobial tests
The antimicrobial properties of the PVC/CYH/CV
films were assessed using the agar-diffusion test. Round
specimens (8 mm in diameter) were placed on Petri
dishes with the nutrient agar inoculated with the
dispersion of microorganisms (a concentration of CFU
1.0 × 107 mL–1). The samples were tested against gram-
negative Escherichia coli (EC) 4517, gram-positive
Staphylococcus aureus (SA) 4516, and yeast Candida
albicans (CA) CCN 8215. After a incubation 72 h at
23 °C for the yeast and a incubation 24 h at 37 °C for
bacteria, the dimensions of the inhibition zones were
measured in four directions, and the average values were
used to calculate the diameter of the circle-zone inhibi-
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tion area and its standard deviation. All the tests were
done in triplicates.
2.3.5 Release of CV and plasticizers from the PVC
matrix
Round specimens with a diameter of 12.7 mm were
cut from the PVC/CYH/CV samples to be used in the
release-profile study of CV in the water and physiolo-
gical-solution environment. One specimen was always
placed in a beaker with 50 mL of elution liquid and the
beaker was shaken at 60 r/min to ensure a good homo-
genization of the liquid media. The measurement of the
CV release was performed with a UV-VIS spectropho-
tometer Cary 300 (VARIAN, USA) equipped with a
sipper (a peristaltic pump) and a flow cell (a cuvette).
The whole spectral range (200–800 nm) was monitored
and the spectra were recorded in the preselected time
intervals covering representatively the full time range of
each individual release experiment. The same procedure
was used for obtaining the reference leachate for the
specimens cut from the neat PVC sample with the
thickness of 0.5 mm obtained by hot pressing at 170 °C
for 5 min to evaluate the release of the plasticizers after
three days, which was done to investigate the influence
of either the CV addition or the preparation process on
the release of the plasticizers from the PVC matrix. The
absorbance value at the wavelength of 580 nm was
chosen for a quantitative evaluation of the observed
release profile of CV because this is the position of the
absorption maximum of CV in the elution medium. The
data were then converted to the concentration of the
released CV using calibration curves. The data were
fitted with a non-linear fitting procedure using the
Lavenberg-Marquart algorithm incorporated in the
Origin 7.0 software.
3 RESULTS AND DISCUSSION
3.1 Infrared absorption spectroscopy
The aim of the FTIR analysis was to study a possible
modification of the PVC material with the preparation
process and an addition of CV. In Figure 1, the FTIR
spectra of the neat PVC (pellets), the processed
PVC/CYH sample and the modified PVC/CYH/CV
material are plotted. The infrared absorption spectrum of
an unplasticized polyvinyl chloride contains the bands
typical for the aliphatic CH groups at their most typical
positions, except that, due to the CH2 deformation
vibration, a band is shifted by about 30 cm–1 to the lower
wavenumbers, nearly to 1430 cm–1 as typically observed
for PVC. In addition to the aliphatic CH bands, the
spectra of PVC contain contributions due to the C-Cl
vibrations that can be found as a weak band at 1425 cm–1
and as a medium-intensity band at 959 cm–1. The most
intense and significant band for the C-Cl vibration at
610 cm–1 cannot be observed due to the range of
measurement. In general, the spectrum of the neat PVC
material is greatly affected by the presence of plasti-
cizers and dominated by their absorption bands. The
manifestation of the polymer matrix is, therefore, quite
weak. The most prominent band at 1725 cm–1 can be
assigned to the carbonyl group (C=O) stretching mode
typically observed for the plasticizers. It can be expected
that the medical-grade PVC contains the additives
circumventing the crucial plasticizer migration problem
associated with the softened PVC. The position of this
peak is too low for the aliphatic low-molecular plasti-
cizers such as dioctyl-sebacate, citrate or adipate esters.
On the other hand, a common phthalic ester plasticizer
with a typical manifestation of the carbonyl group at
1720 cm–1 cannot be successfully used as a medical
material intended for modern indwelling applications. A
careful analysis of the wavenumber region between 1500
cm–1 and 1650 cm–1 revealed that there is a quadruplet of
peaks at positions (1540, 1580, 1600 and 1637) cm–1,
while the phthalic ester plasticizers only display doublets
at 1580 cm–1 and 1600 cm–1. Alkyde (based on vegetable
fatty acids) polyanhydrides were found as the highest
scoring records in the available IR spectra database20;
however, the exact identification was impossible. There
is virtually no difference between the spectra recorded
for the neat material and for the PVC/CYH sample,
proving that the RB3 composition did not change during
the solution-casting process and that no solvent residuals
were manifested.
The IR absorption spectrum of the PVC/CYH/CV
sample displays all the characteristic peaks of CV in
addition to the aforementioned spectral features of the
plasticized medical-grade PVC; namely, 1587 cm–1 due
to the C=C stretching in phenyl rings, 1365 cm–1 due to
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Figure 1: FTIR ATR spectra of neat PVC pellets (curve 3), PVC/CYH
film (curve 2) and PVC/CYH/CV film (curve 1) samples. The region
between 2800–1800 cm–1 is hidden in the graph as no absorption
peaks were manifested.
Slika 1: FTIR ATR-spektri vzorcev gladkih PVC-pelet (krivulja 3),
PVC/CYH-plast (krivulja 2) in PVC/CYH/CV-plast (krivulja 1). Pod-
ro~je 2800–1800 cm–1 je skrito v grafu, ker tam ni bilo izrazitih
absorpcijskih vrhov.
the C-H deformation vibrations in methyl groups, 1174
cm–1 due to the C-H in-plane deformation in 1,3,5
substituted aromatic ring, and 1128 cm–1 due to the C-N
stretching vibration in trisubstituted aromatic amines.
3.2 SEM analysis
SEM images were obtained for the freeze-fracture
surfaces of the films prepared with CV. The PVC/CYH/
CV film morphology before the immersion into the
liquid media is shown in Figure 2a and the morphology
of the PVC/CYH/CV film after the release-profile
measurement is shown in Figure 2b. First, there are no
observable crystals of CV in the polymer matrix, and
second, there is no observable change in the material
after the release test.
3.3 Tensile tests
The influence of the PVC modification with CV on
the mechanical properties of the material prepared by
casting from a CYH solution can be seen in Table 1
where the measured values with their standard deviations
are summarized. The mechanical properties of the PVC/
CYH film and the PVC/CYH/CV film are very similar.
The Young’s modulus of PVC/CYH and PVC/CYH/CV
is about 5 MPa and the tensile stress at break is about
11–13 MPa. The only property showing a slight diffe-
rence between the samples is the strain at break. The
PVC with CV shows a higher deformation (elongation)
ability than the pure PVC sample, which can be consi-
dered as an advantage of the material with the additive.
Moreover, the obtained result is in accordance with the
microscopic observation, both testifying a good disper-
sion (blending) of CV in the material.
Table 1: Selected mechanical properties of the PVC/CYH and
PVC/CYH/CV samples and their standard deviations
Tabela 1: Izbrane mehanske lastnosti vzorcev PVC/CYH in






PVC/CYH 5.0 ± 0.6 490 ± 40 11 ± 3
PVC/CYH/CV 4.8 ± 0.4 620 ± 50 13 ± 3
3.4 Antimicrobial activity
The results of the antimicrobial-activity halo-zone
test against S. aureus, E. coli and C. albicans, performed
with the agar-diffusion test method, are presented in
Table 2, while Figure 3 demonstrates the inhibition
zones around the samples of the antimicrobial material
(PVC/CYH/CV) studied with the agar-diffusion test. The
obtained values show that the pure PVC material has no
antimicrobial properties, but the PVC with CV shows an
activity against all the tested microorganisms.
Table 2: Antimicrobial activity expressed as inhibition-zone diameters
and their standard deviations for PVC/CYH and PVC/CYH/CV
Tabela 2: Protimikrobna aktivnost, izra`ena kot premer podro~ja
zaviranja in njegov standardni odmik za PVC/CYH in PVC/CYH/CV
SAMPLE SA EC CA
PVC/CYH (mm) 0 0 0
PVC/CYH/CV (mm) 14.8 ± 0.9 10.3 ± 1.0 15 ± 3
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Figure 4: Release profile of CV from PVC/CYH/CV in the deminera-
lised water. The experimental data points are represented by full-circle
symbols; curve Y represents equation (3) fitted into the data; curves 1,
2 and 3 represent the single-term contributions to curve Y,
respectively. The inset graph shows detailed data from the initial stage
of the experiment.
Slika 4: Profil spro{~anja CV iz PVC/CYH/CV v demineralizirani
vodi. Eksperimentalni podatki so prikazani s polnimi krogci, krivulja
Y ponazarja ena~bo (3), urejeno s podatki; krivulje, ozna~ene z 1, 2 in
3 so posamezni prispevki h krivulji Y. Vstavljeni diagram prikazuje
podrobne podatke iz za~etka preizkusa.
Figure 2: Microphotographs of: a) PVC/CYH/CV before immersion
and b) after 3 d in the liquid
Slika 2: Posnetka: a) PVC/CYH/CV pred potopitvijo v teko~ino in b)
po 3 d
Figure 3: Photographs of Petri dishes after cultivation in the agar-test
diffusion zone against: a) S. aureus, b) E. coli, c) C. albicans
Slika 3: Posnetki petrijevke po kultiviranju v difuzijski coni preizkusa
z agarjem proti: a) S. aureus, b) E. colli, c) C. albicans
3.5 Release profile of CV from PVC/CYH/CV films
The obtained release profiles are shown in Figures 4
and 5 where the dependences of the CV concentration in
the elution liquids are plotted in dependence on the
release time for demineralised water and physiological
solution, respectively. According to the literature, the
first-order kinetic model can be a suitable formal kinetic
description of the process of a water-soluble compound
release from an insoluble polymer matrix to the liquid
medium although it cannot be straightforwardly related
to the sample geometry and it is difficult to concep-
tualize this mechanism on a theoretical basis.21
The release rate of the model compound (CV in our
case) that obeys first-order kinetics can be expressed









where c is the concentration of the model compound in
the elution media, the expression on the left side of the
equation is the release rate defined as the concentration
increase rate in the elution medium (directly obtained
from absorbance, which is the observable quantity in
this study), t is the release time, –1 is the first-order
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where parameter Cmax is the integration constant repre-
senting the maximum achievable concentration of the
model compound in the elution media for the infinite
time. With respect to the second boundary condition, it
is assumed that the initial concentration of the model
compound is zero in the liquid media at the beginning of
all the experiments. The rest of the variables and con-
stants have the same meanings as in equation (1).
It can be expected that this formal description only
relates to a limited concentration range and to certain
boundary conditions. According to our observations,
several mechanisms can be active at different time scales
during the release process and, thus, it is reasonable to
extend the kinetic description by one or two more terms
for the first-order processes if they differ significantly in
their rate constants, i.e., by orders of magnitude. The
following equation represents the extension of equation
(2) for three formally independent and additive contri-
butions to the release process:

























where C1, C2, C3 represent the maximum contribution of
each process to the infinite time Cmax concentration. The
rest of the variables and constants have the same
meanings as in equation (2) with the indexes showing
their relations to the respective process. It is obvious
that:
C C C C1 2 3+ + = max (4)
For the two processes involved in the release, equa-
tion (3) can be simplified by omitting the third term.
Obtained equation (3) was fitted into the experimen-
tal data as can be seen in Figure 4 representing the water
and Figure 5 representing the physiological solution
where the two-term variant was used. The contributions
of each process are plotted separately with simulated
curves for a better clarity. The obtained parameters are
summarized in Table 3. This mathematical analysis was
performed with a full awareness of the fact that the terms
in equation (3) are not sequential but running parallel as
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Figure 5: Release profile of CV from PVC/CYH/CV in the physiolo-
gical solution. The experimental data points are represented by
full-circle symbols, curve Y represents simplified equation (3) without
the third term fitted into the data; curves 1 and 2 represent the single-
term contributions to curve Y, respectively. The inset graph shows
detailed data from the initial stage of the experiment.
Slika 5: Profil spro{~anja CV iz PVC/CYH/CV v fiziolo{ki raztopini.
Eksperimentalni podatki so prikazani kot simboli polnega kroga,
krivulja Y ponazarja poenostavljeno ena~bo (3) brez vklju~itve tretje-
ga izraza v podatke; krivulji z oznako 1 in 2 pomenita posamezen pri-
spevek h krivulji Y. Vstavljeni diagram prikazuje podrobne podatke iz
za~etka preizkusa.
Table 3: Fitting-equation parameters and their standard errors
describing the release profile of CV from the polymer matrix in the
PVC/CYH/CV sample
Tabela 3: Parametri urejanja ena~b in njihove standardne napake, ki
opisujejo profil spro{~anja CV iz polimerne osnove v vzorcu
PVC/CYH/CV
Environment Water Physiologicalsolution
Cmax /(μg/L) 20.19 ± 0.14 11.15 ± 0.24
C1/(μg/L) 5.20 ± 0.12 2.38 ± 0.06
T1/min 15.2 ± 0.7 66 ± 3
C2/(μg/L) 3.86 ± 0.16 8.63 ± 0.21
T2/min 256 ± 24 4340 ± 220
C3 /(μg/L) 11.09 ± 0.14 n. a.
T3/min 2488 ± 98 n. a.
they use the common time and start at t = 0. However,
the differences in the rate-constant magnitude separate
them to an acceptable level resulting in a good approxi-
mation. Each process (term) dominates its own time-
scale window and relies on its specific concentration
range as it can be seen from the graphs.
The first exponential component (the term with the
shortest time constant, 1) probably represents the release
of CV from the matrix surface, because this process is
the shortest and could only be limited by the CV solu-
bility in water that is 10 g/L as indicated by the supplier.
It is evident, that even the highest CV concentrations in
the elution medium are far from approaching this limit.
In the case of the physiological solution that shares a
chloride anion with CV the solubility must be lower due
to the solubility-product limitation; however, even here
the solubility is more than several orders in magnitude
higher than the observed concentrations. The value of the
solubility product is Ks = 6 × 10–4 mol2 dm–6 estimated
roughly from the CV solubility in water. The solubility
in the physiological solution can be derived by solving
the following equation:
(x + 0.154 mol/L)x = Ks (5)
where x is the maximum CV concentration and 0.154
mol/L is the chloride concentration in the physiological
solution. The equation gives only one positive root, x =
0.0038 mol/L, which corresponds to the CV concen-
tration of 1.55 g/L. This value is about six and a half
times lower than the limitation for the sample in
distilled water.
The second phase of the release process is slower
because the CV readily available from the matrix surface
is already depleted and the CV from the subsurface
layers of the film needs to cross an energetic barrier
before being released into the demineralised water.
The third phase is characterized by a further signi-
ficant decrease-release rate that can be ascribed to the
diminishing of the gradient between the film surface and
the solution layer in its proximity and to the depletion of
the extractable CV in the subsurface of the film. Accord-
ing to the macroscopic observation, the material changed
neither its colour nor any other property after its
immersion into the liquid for several days. No dimension
or significant mass changes were observed which con-
firms there was no swelling or matrix-component disso-
lution. Therefore, we believe that the CV located in the
deeper layers of the material is not released into the
solution in the relevant time horizon.
These three phases were observed for the sample
immersed in the water. The sample in the demineralised
water has a higher saturation value (Cmax) than the
sample in the physiological solution. In general, this
might be caused by the omnipresence of chloride anions
with a relatively high concentration diminishing all the
gradients discussed above in the case of pure water.
The first and second processes of the sample in the
physiological (saline) solution were slow and the third
process was not observed at all. In this case, the solu-
bility of CV is influenced by the presence of the chloride
anion, which is commonly shared between CV and the
physiological solution. Moreover, the CV molecule can
leave the polymer matrix as a CV+ cation and a Cl–
anion, always in a pair, i.e., in the ratio of 1 : 1 due to the
electroneutrality condition that must always be kept.
This condition is obviously satisfied in the case of water,
whereas in the case of the physiological solution this pair
would be released into a medium with a high con-
centration of chloride anions. Alternatively, a lone CV+
cation can be released into the liquid with a concurrent
counter transport of a Na+ cation to the matrix. Both
options can be considered for significantly slowing and
limiting the diffusion process, so only the first two
phases were observed within the time scale of several
days.
3.6 Plasticizer role in the release of CV from PVC/
CYH/CV films
Although the neat PVC material has been approved
for medical use and can be considered as safe from the
point of view of the release of the contained plasticizer
or plasticizers, it must be re-evaluated after being mixed
with CV as the eventual synergic effects cannot be
excluded and the release of the plasticizer could be
enhanced by adding other species to the compound. A
simplified test was performed analysing the absorption
spectra in the wavelength region where both the plasti-
cizer and CV absorb light.
The graph in Figure 6 shows the UV absorption
spectra of the leachates obtained for the PVC/CYH/CV
and neat PVC samples after a three-day elution in water.
The third curve represents the absorption spectrum of
CV in water with the same concentration as that in the
liquid media collected for PVC/CYH/CV. It can be
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Figure 6: UV absorption spectra recorded for the CV solution in
water (curve 2), leachate from the neat PVC specimen (curve 1) and
leachate obtained for the PVC/CYH/CV specimen (curve 3). For
details, see the text.
Slika 6: Posneta absorpcija UV-spektra za raztapljanje CV v vodi (kri-
vulja 2), izcedna voda iz ~istega PVC-vzorca (krivulja 1) in izcedna
voda iz PVC/CYH/CV-vzorca (krivulja 3). Za podrobnosti glej tekst.
clearly seen, that there is no enhancement of the plasti-
cizer release and that only a simple additivity of the
signals takes place as the absorption spectrum recorded
for PVC/CYH/CV is approximately the sum of the
spectra of the plasticizer released from the neat PVC
sample into the liquid medium and the CV solution. The
test for the physiological solution showed the same
result, but it is not shown here for the sake of brevity.
4 CONCLUSIONS
A model organic antimicrobial polymeric PVC/CYH/
CV system based on medical-grade poly(vinyl chloride)
and crystal violet was prepared with the solvent-casting
technique. The work was focused on investigating the
effects of the used technique for preparing and entering
substances and it was shown that the CYH solvent and
the model CV-active substance did not have any adverse
influence on the chemical structure, morphology and
mechanical properties.
The prepared solvent-cast materials can be used in
the form of a film, as a volume material or as an additive
for further compounding but, preferentially, we aim at
various coatings and thin-film applications on the surfa-
ces of medical devices or other plastic articles wherever
this technique allows hopes for a good adhesion and
compatibility with the substrate material, especially
when coated on the plastic articles made of the same neat
PVC resin.
The antimicrobial activity was investigated using the
agar-diffusion test method and the PVC/CYH/CV
material manifested a good antimicrobial activity against
gram-positive S. aureus, gram-negative E. coli and yeast
C. albicans. Although the material is an organic-doped
antimicrobial polymer system, the release profile of CV,
as the representative model compound with a large orga-
nic cation and halide anion, to the demineralised water
and physiological solution simulating body liquids is
appropriately slow allowing a long-lasting mild delivery
effect of the active species on the closest proximity of
the place of insertion or application. Next, no adverse
effect of either the CV addition to the PVC matrix or the
preparation process on the release of the plasticizers
from the PVC matrix was observed.
These results suggest that the prepared model mate-
rial has a potential in medical plastic industries and the
obtained knowledge can be generalised to a certain
degree, without losing its relevance, covering the whole
class of modelled compounds and used for a further
development of the materials or coatings for PVC
medical devices and hygienic products.
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